Progentos Therapeutics Closes $65 Million Series A Financing to Advance Treatments for Multiple Sclerosis and Other Degenerative Diseases May 20, 2024
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024 May 15, 2024
TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update May 15, 2024
Be Biopharma Announces New Preclinical Data for Novel B Cell Medicine for the Potential Treatment of Hypophosphatasia May 13, 2024
